Roivant does not view - and has never viewed - Axovant as simply a 'vehicle' for developing intepirdine, but instead as a platform for the development of high-impact drugs in dementia and the neuroscience field more generally.
-Vivek Ramaswamy
A curated listing of popular authors.
A curated listing of popular topics.
